Improving Empiric Antibiotic Selection for Patients With Cancer Hospitalized With Infection: Secondary - Top-Institutions - MDSpire

Improving Empiric Antibiotic Selection for Patients With Cancer Hospitalized With Infection: Secondary

  • By

  • Shruti K. Gohil

  • Taliser R. Avery

  • Ken Kleinman

  • Edward Septimus

  • Amarah Mauricio

  • Kenneth E. Sands

  • Neha Varma

  • Selsebil Sljivo

  • Kaleb Roemer

  • William S. Cooper

  • Russell E. Poland

  • Robert A. Weinstein

  • Samir M. Fakhry

  • Jeffrey Guy

  • Julia Moody

  • Micaela H. Coady

  • Kim N. Smith-Sells

  • Mary K. Hayden

  • David W. Kubiak

  • Chenette Burks

  • Richard Platt

  • Susan S. Huang

  • Meghan A. Baker

  • June 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Harvard Pilgrim Health Care Institute
    Harvard Pilgrim Health Care Institute

    Boston, MA

    Key Differentiators

    • Infectious Disease

  • #2

    Geneva University Hospitals
    Geneva University Hospitals

    Geneva, Switzerland

    Key Differentiators

    • Infectious Disease

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Infectious Disease

  • #4

    Hospital St. Georg
    Hospital St. Georg

    Leipzig, Germany

    Key Differentiators

    • Infectious Disease

Original Source(s)

Improving Empiric Antibiotic Selection for Patients With Cancer Hospitalized With Infection: Secondary

  • by Shruti K. Gohil, Taliser R. Avery, Ken Kleinman, Edward Septimus, Amarah Mauricio, Kenneth E. Sands, Neha Varma, Selsebil Sljivo, Kaleb Roemer, William S. Cooper, Russell E. Poland, Robert A. Weinstein, Samir M. Fakhry, Jeffrey Guy, Julia Moody, Micaela H. Coady, Kim N. Smith-Sells, Mary K. Hayden, David W. Kubiak, Chenette Burks, Richard Platt, Susan S. Huang, Meghan A. Baker

  • June 10, 2026

Related Content

Reduced DPP9 levels sensitize experimental breast tumors to combinatory treatment with irradiation and Olaparib

A multi-center cross-sectional study to explore cancer patients’ views on facilitators and barriers for the implementation of oncological exercise therapy

Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer